Physician

Vance T Hartke, MD

According to 2025 Medicare claims, Vance Hartke, MD (NPI: 1295260453) practices gastroenterology in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is GASTROINTESTINAL ASSOCIATES S.C. (NPI: 1760546949; TIN: 391735324) and primary practice location at 54401-4152.

Hartke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 331 traditional Medicare patients, billed 5,789 HCPCS/CPT codes, and received $145,705 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 643 prescription claims across 218 beneficiaries totaling $559,109 in drug costs, led by Mesalamine (Mesalamine). Open Payments data shows 2 records totaling $134. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$73K$146K2023 Medicare payment: $33,558 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $145,705 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023811,319$33,558
20243315,789$145,705

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$280K$559K2017 Drug cost: $2,103 (USD; Tot_Drug_Cst)2018 Drug cost: $899 (USD; Tot_Drug_Cst)2019 Drug cost: $407 (USD; Tot_Drug_Cst)2020 Drug cost: $1,291 (USD; Tot_Drug_Cst)2021 Drug cost: $1,001 (USD; Tot_Drug_Cst)2022 Drug cost: $1,973 (USD; Tot_Drug_Cst)2023 Drug cost: $28,323 (USD; Tot_Drug_Cst)2024 Drug cost: $559,109 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172237$2,103
2018N/R21$899
2019N/R13$407
20201535$1,291
20211117$1,001
20222233$1,973
202363128$28,323
2024218643$559,109

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare110112$179
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6565$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4751$92
45380Biopsy of large bowel using a flexible endoscope5557$43
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope7475$41

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MesalamineMesalamine211,226$16,334
LinzessLinaclotide20600$10,425
MotegrityPrucalopride Succinate13570$9,971
OmeprazoleOmeprazole1279,629$1,845
Dexlansoprazole DrDexlansoprazole11330$1,700

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$134ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vance T. Hartke, MD?

Tedicare shows public-source Medicare data for Vance T. Hartke, MD (NPI 1295260453), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vance T. Hartke, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vance T. Hartke, MD?

Vance T. Hartke, MD is linked to GASTROINTESTINAL ASSOCIATES S.C. (billing NPI 1760546949) in the available physician profile data.

Does Vance T. Hartke, MD have Open Payments data?

Vance T. Hartke, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.